Dear Editor,
Adverse drug reaction (ADRs) is response to a drug which is noxious and unintended and which occurs at doses normally used in human for the prophylaxis, diagnosis or treatment of disease, or for the modification of physiological function.
1 ADRs are one of the major public health issues and found to cause of morbidity and mortality. 2 The impact of ADRs in India is significant and leads to the enormous burden to the public. Therefore, Ministry of Health & Family Welfare (MoHFW), Government of India launched a nationwide Pharmacovigilance Programme of India (PvPI) in the year 2010 to monitor the safety of drugs. Indian Pharmacopoeia Commission (IPC) under the MoHFW functions as National Coordination Centre (NCC) for PvPI. To monitor and report ADRs to NCC, teaching hospitals and corporate hospitals have been identified as ADRs Monitoring Centres (AMCs).
3-5 ADR reporters (healthcare professionals) who is not a part of AMC can also fill the suspected ADR reporting form ( Figure 1 ) and submit to nearby AMC (available at www.ipc.gov.in). Reporter can call on 'PvPI-Helpline-1800 180 3024' for further assistance in ADRs reporting. 6 To report ADRs simply and quickly, NCC introduced android mobile application which will also enhance the participation of private practitioners. All types of suspected adverse events with all pharmaceutical products irrespective of whether they are known or unknown, serious or non-serious and frequent or rare can be reported. The obtained information is entered in the drug safety database Vigiflow TM (webbased software for International Drug Monitoring in the WHO Programme), analysed and assessed by the experts to identify new signals. This is also used as a main source for identifying and reducing the risks associated with the drugs. Submission of ADRs report does not have any legal implication on the reporter and also the confidentiality of the reporter and patients will be maintained. The provided information contributes to promote patients' safety in many ways such as generation of drug safety data on Indian population, for taking appropriate regulatory decisions, educational initiatives for healthcare professionals for promoting safety of medicines, benefit-risk assessment, updating prescribing information leaflet (ADRs, warning, contraindication etc) and promote rational use of medicines. Therefore, healthcare providers are encouraged to report ADRs for better understanding and to safeguard the health of Indian population.
